{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:12Z","timestamp":1761895812699},"reference-count":9,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: Genetic background plays a role in multiple myeloma susceptibility. Several single-nucleotide polymorphisms (SNP) associated with genetic susceptibility to multiple myeloma were identified in the last years, but only a few of them were validated in independent studies.<\/jats:p>\n               <jats:p>Methods: With the aim to conclusively validate the strongest associations so far reported, we selected the polymorphisms rs2227667 (SERPINE1), rs17501108 (HGF), rs3136685 (CCR7), rs16944 (IL1B), rs12147254 (TRAF3), rs1805087 (MTR), rs1800629 (TNF-\u03b1), rs7516435 (CASP9), rs1042265 (BAX), rs2234922 (mEH), and rs1801133 (MTHFR). We genotyped them in 1,498 multiple myeloma cases and 1,934 controls ascertained in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium, and meta-analyzed our results with previously published ones.<\/jats:p>\n               <jats:p>Results: None of the selected SNPs were significantly associated with multiple myeloma risk (P value range, 0.055\u20130.981), possibly with the exception of the SNP rs2227667 (SERPINE1) in women.<\/jats:p>\n               <jats:p>Conclusions: We can exclude that the selected polymorphisms are major multiple myeloma risk factors.<\/jats:p>\n               <jats:p>Impact: Independent validation studies are crucial to identify true genetic risk factors. Our large-scale study clarifies the role of previously published polymorphisms in multiple myeloma risk. Cancer Epidemiol Biomarkers Prev; 23(4); 670\u20134. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/1055-9965.epi-13-1115","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T01:17:34Z","timestamp":1392254254000},"page":"670-674","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetic Variants and Multiple Myeloma Risk: IMMEnSE Validation of the Best Reported Associations\u2014An Extensive Replication of the Associations from the Candidate Gene Era"],"prefix":"10.1158","volume":"23","author":[{"given":"Alessandro","family":"Martino","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Daniele","family":"Campa","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Artur","family":"Jurczyszyn","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Joaqu\u00edn","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Moreno","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Judit","family":"Varkonyi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Charles","family":"Dumontet","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Federica","family":"Gemignani","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Krzysztof","family":"Jamroziak","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Anna","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Svend E. Hove","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Vibeke","family":"Andersen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"},{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Manuel","family":"Jurado","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"},{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Stefano","family":"Landi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Anna Maria","family":"Rossi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Fabienne","family":"Lesueur","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Herlander","family":"Marques","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"},{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Marek","family":"Dudzi\u0144ski","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Marzena","family":"W\u0105tek","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Victor","family":"Moreno","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Enrico","family":"Orciuolo","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Mario","family":"Petrini","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"},{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"},{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Rafael","family":"R\u00edos","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"},{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Juan","family":"Sainz","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"},{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Ulla","family":"Vogel","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Gabriele","family":"Buda","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Annette Juul","family":"Vangsted","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]},{"given":"Federico","family":"Canzian","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Genomic Epidemiology Group, 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Hematology, Cracow University Hospital, Cracow; 4Medical University of \u0141odz; 5Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, \u0141odz; 6Rzeszow Regional Hospital, Rzeszow; 7Holycross Cancer Center, Kielce, Poland; 8Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; 9Morales Meseguer General University Hospital, Murcia; 10University Hospital of Salamanca, Salamanca; 11Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer\/University of Granada\/Andalusian Regional Government; 12Hematology Department, Virgen de las Nieves University Hospital, Granada; 13IDIBELL\u2014Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; 14Semmelweis University, Budapest, Hungary; 15Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM) UMR 1052\/CNRS 5286"}]}],"member":"1086","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"2022060920345179400_bib1","first-page":"625","article-title":"Genetics and molecular epidemiology of Multiple Myeloma: the rationale for the IMMEnSE consortium (review)","volume":"40","author":"Martino","year":"2012","journal-title":"Int J Oncol"},{"key":"2022060920345179400_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0609.2011.01700.x","article-title":"Genetic variations in multiple myeloma I: effect on risk of multiple myeloma","volume":"88","author":"Vangsted","year":"2012","journal-title":"Eur J Haematol"},{"key":"2022060920345179400_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ng.993","article-title":"Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk","volume":"44","author":"Broderick","year":"2011","journal-title":"Nat Genet"},{"key":"2022060920345179400_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2141.2012.09244.x","article-title":"Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma","volume":"158","author":"Martino","year":"2012","journal-title":"Br J Haematol"},{"key":"2022060920345179400_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ng.2733","article-title":"Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk","volume":"45","author":"Chubb","year":"2013","journal-title":"Nat Genet"},{"key":"2022060920345179400_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/1055-9965.EPI-08-0778","article-title":"Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma","volume":"18","author":"Birmann","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060920345179400_bib7","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1080\/10428190701615892","article-title":"Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma","volume":"48","author":"Abazis-Stamboulieh","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"2022060920345179400_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hon.954","article-title":"Variation in innate immunity genes and risk of multiple myeloma","volume":"29","author":"Purdue","year":"2010","journal-title":"Hematol Oncol"},{"key":"2022060920345179400_bib9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.leukres.2009.03.013","article-title":"Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk","volume":"33","author":"Hosgood","year":"2009","journal-title":"Leuk Res"}],"container-title":["Cancer Epidemiology, Biomarkers &amp; Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/23\/4\/670\/2277976\/670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/23\/4\/670\/2277976\/670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:48:58Z","timestamp":1654822138000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cebp\/article\/23\/4\/670\/70219\/Genetic-Variants-and-Multiple-Myeloma-Risk-IMMEnSE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,2]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1055-9965.epi-13-1115","relation":{},"ISSN":["1055-9965","1538-7755"],"issn-type":[{"value":"1055-9965","type":"print"},{"value":"1538-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}